T. Rowe Price Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,352,252
| Closed | -$28.3M | – | 662 |
|
|
2023
Q4 | $28.3M | Buy |
4,352,252
+253,385
| +6% | +$1.65M | 0.02% | 456 |
|
|
2023
Q3 | $38.7M | Buy |
4,098,867
+183,000
| +5% | +$1.73M | 0.03% | 401 |
|
|
2023
Q2 | $54.7M | Buy |
3,915,867
+177,981
| +5% | +$2.49M | 0.04% | 366 |
|
|
2023
Q1 | $70.1M | Buy |
3,737,886
+130,233
| +4% | +$2.44M | 0.05% | 317 |
|
|
2022
Q4 | $49.7M | Buy |
3,607,653
+1,965,560
| +120% | +$27.1M | 0.04% | 355 |
|
|
2022
Q3 | $31.4M | Buy |
+1,642,093
| New | +$31.4M | 0.03% | 399 |
|